50 likes | 156 Views
These epidemiologists used comprehensive country-specific data from population-based studies, which were published in peer-reviewed journal articles, to arrive at a meaningful
E N D
EpiCast Report: Peripheral Arterial Disease - Epidemiology Forecast to 2024 By RnRMarketResearch.com Publisher Name : GlobalData Date: 06-Oct-2015 No. of pages: 72 Single User License: US $3995 Browse more Reports on Clinical Trial at http://www.rnrmarketresearch.com/reports/life-sciences/pharmaceuticals/clinical-trial . ©http://www.rnrmarketresearch.com/ ; sales@RnRMarketResearch.com +1 888 391 5441
EpiCast Report: Peripheral Arterial Disease - Epidemiology Forecast to 2024 This report forecast an increase in the total prevalent cases of PAD in the 8MM, from 66,433,407 in 2014 to 94,490,894 cases in 2024 with an annual growth rate (AGR) of 4.22%. Additionally the number of diagnosed incident cases of PAD is expected to grow from 7,900,097 cases in 2014 to 10,797,781 cases in 2024 at an AGR of 3.67%. These epidemiologists used comprehensive country-specific data from population-based studies, which were published in peer-reviewed journal articles, to arrive at a meaningful, in-depth analysis and forecast for the total and diagnosed prevalent cases of PAD, asymptomatic and symptomatic cases of PAD, PAD cases with IC, cases of PAD with CLI, cases of PAD with comorbid hypertension, and cases of PAD with comorbid diabetes. Additionally, sex and age-specific segmentation for the total prevalent cases and the diagnosed prevalent cases of PAD was obtained. ©http://www.rnrmarketresearch.com/ ; sales@RnRMarketResearch.com +1 888 391 5441
EpiCast Report: Peripheral Arterial Disease - Epidemiology Forecast to 2024 Scope For EpiCast Report: Peripheral Arterial Disease - Epidemiology Forecast to 2024 • The Peripheral Arterial Disease (PAD) EpiCast Report provides an overview of the risk factors, comorbidities, and global trends for PAD in the eight major markets (8MM) (US, France, Germany, Italy, Spain, UK, Japan, and Urban China). It includes a 10-year epidemiological forecast of the total and diagnosed prevalent cases of PAD segmented by sex and age (beginning at 35 years and ending at =85 years) in these markets. Additionally, both the total and diagnosed prevalent cases of PAD are further segmented in symptomatic PAD, asymptomatic PAD, PAD with intermittent claudication (IC), PAD with critical limb ischemia (CLI), PAD with hypertension, and PAD with diabetes. • The PAD epidemiology report is written and developed by Masters-and PhD-level epidemiologists. • The EpiCast Report is in-depth, high quality, transparent and market-driven, providing expert analysis of disease trends in the 8MM. ©http://www.rnrmarketresearch.com/ ; sales@RnRMarketResearch.com +1 888 391 5441
EpiCast Report: Peripheral Arterial Disease - Epidemiology Forecast to 2024 Reasons to Buy: • Develop business strategies by understanding the trends shaping and driving the global PAD market. • Quantify patient populations in the global PAD market to improve product design, pricing, and launch plans. • Organize sales and marketing efforts by identifying the sex and age groups that present the best opportunities for PAD therapeutics in each of the markets covered. ©http://www.rnrmarketresearch.com/ ; sales@RnRMarketResearch.com +1 888 391 5441
EpiCast Report: Peripheral Arterial Disease - Epidemiology Forecast to 2024 For more details contact Mr. Ritesh Tiwari :sales@rnrmarketresearch.com/ +18883915441 RnRMarkertResearch RnRMarketResearch.com, an online repository of market research reports, offers in-depth analysis of over 5000 market segments. RnRMarket Research library has syndicated reports by leading market research publishers across the globe. ©http://www.rnrmarketresearch.com/ ; sales@RnRMarketResearch.com +1 888 391 5441